Metastasis Breast
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Letrozole Plus Metronomic Capecitabine as First-line Treatment for Patients With Recurrent or Metastatic Breast Cancer (NCT04942899) | Assiut University | 2023-08-30 |
Track Metastasis Breast automatically
Every clearance here is in the API, with alerts when new ones post.